VB-201, an oxidized phospholipid mimic which is orally available, binds to TLR2 and CD14 to limit downstream inflammatory pathways and has beneficial effects on atherosclerosis (203) and experimental autoimmune encephalomyelitis (204). This evidence concerns the gene TLR2 and atherosclerosis.